
Developing a Model of Care for Home Infusions of Natalizumab for People With Multiple Sclerosis
Author(s) -
Tim Schultz,
Anne Thomas,
Paul Georgiou,
Lynette Cusack,
Mahasen Juaton,
Lorraine Simon,
Kimesh Naidoo,
Kevin Webb,
Jonathan Kar,
Janakan Ravindran
Publication year - 2019
Publication title -
journal of infusion nursing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.35
H-Index - 35
eISSN - 1539-0667
pISSN - 1533-1458
DOI - 10.1097/nan.0000000000000343
Subject(s) - natalizumab , multiple sclerosis , medicine , medline , intensive care medicine , psychiatry , political science , law
Natalizumab is an effective treatment for multiple sclerosis that requires 4-weekly infusions that are usually provided in hospital outpatient clinics. In this study, a model of care (MOC), an overarching design for the provision of a health care service, was developed to permit home infusions of natalizumab. The proposed new MOC comprised 9 dimensions, in addition to the central concept of patient-centered care at home. The new MOC is responsive to patient needs and prioritizes the nurse-patient therapeutic relationship. It provides practical examples of patient-centered care to guide clinical practice for this patient population in the home setting.